Atlas Trials

Safety of doTBal® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program

Clinical trial NCT04916899 · COMPLETED

Trial details

NCT number
NCT04916899
Sponsor
Laboratorios Silanes S.A. de C.V.
Status
COMPLETED
Study type
OBSERVATIONAL
Tuberculosis
Start date
2014-11-01
Primary completion
2016-09-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.